Authors: Ugolini, F Charafe-Jauffret, E Bardou, VJ Geneix, J Adelaide, J Labat-Moleur, F Penault-Llorca, F Longy, M Jacquemier, J Birnbaum, D Pebusque, MJ

Citation: F. Ugolini et al., WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type, ONCOGENE, 20(41), 2001, pp. 5810-5817

Authors: Mathoulin-Portier, MP Viens, P Cowen, D Bertucci, F Houvenaeghel, G Geneix, J Puig, B Bardou, VJ Jacquemier, J

Citation: Mp. Mathoulin-portier et al., Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin, ONCOL REP, 7(3), 2000, pp. 675-680

Authors: Jacquemier, J Mathoulin-Portier, MP Valtola, R Charafe-Jauffret, E Geneix, J Houvenaeghel, G Puig, B Bardou, VJ Hassoun, J Viens, P Birnbaum, D

Citation: J. Jacquemier et al., Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3, INT J CANC, 89(1), 2000, pp. 69-73

Authors: Jacquemier, J Eisinger, F Nogues, C Sun, ZZ Guinebretiere, JM Peyrat, JP Geneix, J Lidereau, R Birnbaum, D Sobol, H

Citation: J. Jacquemier et al., Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancers, INT J CANC, 83(1), 1999, pp. 45-49